5 South Korean hospitals to try out Deep Bio’s AI support tool for prostate cancer diagnosis

South Korean medical AI developer Deep Bio is deploying its prostate cancer diagnosis support software to five local hospitals as part of a recently signed trial purchase agreement.

The AI product will be tried out at SMG-SNU Boramae Medical Center, Chungnam National University Sejong Hospital, Korea Institute of Radiological & Medical Sciences, Jeju National University Hospital, and Gyeongsang National University Changwon Hospital. 

WHAT IT’S ABOUT

The trial purchase comes ahead of the full integration of Deep Bio’s DeepDx Prostate Pro into the hospitals’ pathology workflows by November. It is intended to be used to support pathologists in tumour severity determination, confirmation of diagnoses, and research.

The deep learning-based medical software analyses the whole slide image of prostate needle biopsies and automatically classifies the severity of prostate cancer. Based on evaluation studies, this tool showed 98.7% concordance in grade group classification and 96.9% concordance in “no grade” group classification compared with the reference standard created by three pathologists.

THE LARGER TREND

In November last year, Deep Bio received the approval of the Ministry of Food and Drug Safety for DeepDx Prostate Pro. In July this year, the software has been designated as an innovative product by South Korean regulators.

The technology is currently being studied by researchers at the Stanford University School of Medicine, which recently extended its software license deal with the company. 

DeepDx Prostate is also being used by Morphle Labs’ pathologists in India and the US. It is also being distributed around Switzerland and North Africa through Deep Bio’s partnership with Swiss medical device distributor HealthCare Konnect.

ON THE RECORD

In a press statement, CEO Sun-Woo Kim said that “through this trial purchase project, Deep Bio will lead the introduction of digital pathology in Korea as well as accelerate domestic market expansion.”

“We are greatly expecting to prove that our software can be seamlessly integrated into the current pathology workflows, bringing positive changes such as reducing pathologists’ work burden and improving efficiency in real clinical settings,” he added.

Note: This article have been indexed to our site. We do not claim legitimacy, ownership or copyright of any of the content above. To see the article at original source Click Here

Related Posts
Migraine: What to Do When Your Pain Is Dismissed thumbnail

Migraine: What to Do When Your Pain Is Dismissed

Please enable cookies. Error 1005 Ray ID: 83d7c44afb598af9 • 2023-12-30 05:08:46 UTC What happened? The owner of this website (www.webmd.com) has banned the autonomous system number (ASN) your IP address is in (47583) from accessing this website. Was this page helpful? Thank you for your feedback! Cloudflare Ray ID: 83d7c44afb598af9 • Your IP: 89.117.245.16 •
Read More
E-Cigs Show Some Benefit as Smoking Cessation Aid in Clinical Trial thumbnail

E-Cigs Show Some Benefit as Smoking Cessation Aid in Clinical Trial

Pulmonology > Smoking & Tobacco — More people able to abstain from smoking tobacco than after traditional counseling alone by Elizabeth Short, Staff Writer, MedPage Today February 14, 2024 Electronic cigarettes (e-cigarettes) helped people better stick to smoking cessation in the randomized controlled ESTxENDS trial. Participants smoking at least five tobacco cigarettes a day at
Read More
Researchers identify neural signature for Borderline Personality Disorder thumbnail

Researchers identify neural signature for Borderline Personality Disorder

Credit: Unsplash/CC0 Public Domain A new study of a brain region called the rostro-medial prefrontal could potentially advance diagnosis and therapies for Borderline Personality Disorder (BPD). Entitled "Rejection Distress Suppresses Medial Prefrontal Cortex in Borderline Personality Disorder," the research appears in the journal Biological Psychiatry: Cognitive Neuroscience and Neuroimaging. Researchers from The City College of
Read More
Danish campaign targets knowledge about cooling of hot food thumbnail

Danish campaign targets knowledge about cooling of hot food

Most businesses correctly cool down hot food but some violations were found during inspections in Denmark. The Danish Veterinary and Food Administration (Fødevarestyrelsen) investigated whether shops, restaurants and caterers were in control of the refrigeration and cooling process and its management. Overall, 91 percent of the sites subject to unannounced visits knew how to cool…
Read More
Survival Bump in Biliary Cancer With Immunotherapy Plus Chemotherapy thumbnail

Survival Bump in Biliary Cancer With Immunotherapy Plus Chemotherapy

SAN FRANCISCO -- Patients with untreated advanced biliary tract cancer (BTC) had modest but statistically significant improvement in overall survival (OS) with the addition of immunotherapy to chemotherapy, a randomized trial showed. Median OS improved from 11.5 months with placebo and chemotherapy to 12.8 months with durvalumab (Imfinzi) add-on. The survival benefit did not become…
Read More
Index Of News
Total
0
Share